Also Known As
Ozempic · Wegovy · Rybelsus
Overview
Semaglutide is a long-acting GLP-1 analog. FDA approved for diabetes (Ozempic) and weight management (Wegovy). Works by mimicking incretin hormones.
Mechanism of Action
Activates GLP-1 receptors, increasing insulin secretion, reducing glucagon, slowing gastric emptying, and reducing appetite.
Quick Reference
Notes
Titrate slowly to minimize GI side effects. Do not use if history of MTC or MEN2.
Dosing Protocol
Pharmacokinetics
Administration
Special Instructions
Inject same day each week. Rotate injection sites. Oral form (Rybelsus) available - take on empty stomach with small sip of water.
Warnings
Contraindications
Drug Interactions
Possible Side Effects
Legal & Regulatory
Pregnancy
Molecular Data
No sources available yet.
Related Peptides
No community data available yet. Be the first to add this peptide to your inventory!